Die vorliegende Erfindung beschreibt einen theranostischen Artikel, umfassend auf seiner Oberfläche spezifische Erkennungsmarker für Zellen, wobei die Erkennungsmarker ausgewählt sind aus der Gruppe bestehend aus Peptiden, Proteinen, Antikörpern, Antigenen, Aptameren, molekular-geprägten Polymeren und Polynukleotiden.Implantable theranostic articles, comprises specific molecular recognition marker for cells on surface of the theranostic articles, where the recognition marker includes peptides, proteins, antibodies, antigens, aptamers, molecularly-imprinted polymers and polynucleotides. An independent claim is also included for producing the implantable theranostic article with a biofouling reducing or biofouling preventing surface and/or a surface for reducing or preventing thrombus formation, comprising (a) providing an implantable article and (b) providing parts of the surface or the surface of the article with specific recognition marker for cells, where the recognition marker contains peptides, proteins, antibodies, antigens, aptamers, molecularly-imprinted polymers and polynucleotides (ribonucleic acid, deoxyribonucleic acid, peptide nucleic acid, locked nucleic acid).
